Endocyte (ECYT) Removed from Wedbush's Best Ideas List

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/30/2026

1. DLR
2. AVAV
3. VSH
4. CNS
5. CNXC
6. SPY
7. MAMA
8. ABVX
9. CMCSA
10. ABBV

Go back to Endocyte (ECYT) Removed from Wedbush's Best Ideas List

Baird Downgrades Endocyte (ECYT) to Neutral

May 2, 2014 10:17 AM EDT

Baird downgraded Endocyte (NASDAQ: ECYT) from Outperform to Neutral with a price target of $8.00.

For an analyst ratings summary and ratings history on Endocyte click here. For more ratings news on Endocyte click here.

Shares of Endocyte closed at $17.38 yesterday.

... More

Piper Jaffray Downgrades Endocyte (ECYT) to Neutral

May 2, 2014 9:03 AM EDT

Piper Jaffray downgraded Endocyte (NASDAQ: ECYT) from Overweight to Neutral with a price target of $13.50.

For an analyst ratings summary and ratings history on Endocyte click here. For more ratings news on Endocyte click here.

Shares of Endocyte closed at $17.38 yesterday.

... More

Endocyte, Inc. (ECYT) Tops Q1 EPS by 5c; Reports Halt of PROCEED Trial (MRK)

May 2, 2014 8:02 AM EDT

Endocyte, Inc. (NASDAQ: ECYT) reported Q1 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $17.3 million versus the consensus estimate of $15.07 million.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and... More

Endocyte, Inc. (ECYT) trading halted with news pending

May 2, 2014 7:57 AM EDT

Endocyte, Inc. (NASDAQ: ECYT) trading halted with news pending.

... More